ClinicalTrials.govpublic full text
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
hr+/her2- breast cancer, breast cancer, toripalimab, adjuvant chemotherapy, hr-positive her2-negative, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852502
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.